AI-guided modeling reveals single herpes virus weak point that blocks cell entry

Scientists at Washington State University used artificial intelligence and molecular simulations to identify a crucial amino acid interaction in a herpes virus fusion protein that is required for cell invasion. When they engineered a mutation at this site, the virus could no longer fuse with or enter cells, according to a study published in Nanoscale.

Researchers from Washington State University's School of Mechanical and Materials Engineering and Department of Veterinary Microbiology and Pathology collaborated on a study targeting a fusion protein that herpes viruses use to enter cells. This protein undergoes complex shape changes to drive infection, and limited understanding of its dynamics has made vaccine and drug development difficult.

To investigate the problem, professors Jin Liu and Prashanta Dutta turned to artificial intelligence and detailed molecular simulations to analyze thousands of potential interactions among amino acids in the fusion protein, Washington State University reports. They built an algorithm to examine these interactions and then applied machine learning to identify those most likely to be essential for viral entry.

"Viruses are very smart. The whole process of invading cells is very complex, and there are a lot of interactions. Not all of the interactions are equally important—most of them may just be background noise, but there are some critical interactions," Liu said in the university's account of the work.

After simulations highlighted one key amino acid interaction, the team moved to laboratory experiments led by Anthony Nicola in the Department of Veterinary Microbiology and Pathology. By introducing a targeted mutation at this amino acid, they found that the virus could no longer successfully fuse with cells, effectively blocking the herpes virus from entering cells altogether, according to the ScienceDaily summary of the study.

Liu said the computational screening substantially accelerated the research. Experimentally testing interactions one by one would have taken far longer, he noted. "It was just a single interaction from thousands of interactions. If we don't do the simulation and instead did this work by trial and error, it could have taken years to find. The combination of theoretical computational work with the experiments is so efficient and can accelerate the discovery of these important biological interactions," he said.

Although the team confirmed the importance of this specific interaction for viral fusion and entry, they cautioned that many questions remain about how the mutation alters the three-dimensional structure and large-scale motions of the full fusion protein. The researchers plan to continue using simulations and machine learning to explore how small molecular changes propagate across the protein and to narrow down other potentially vulnerable sites.

"There is a gap between what the experimentalists see and what we can see in the simulation," Liu said. "The next step is how this small interaction affects the structural change at larger scales. That is also very challenging for us."

The work, carried out by Liu, Dutta, Nicola and PhD students Ryan Odstrcil, Albina Makio, and McKenna Hull, was funded by the National Institutes of Health and is detailed in the journal Nanoscale under the title Modulation of specific interactions within a viral fusion protein predicted from machine learning blocks membrane fusion.

According to Washington State University, this AI-guided approach could inform future antiviral strategies by helping scientists pinpoint and disrupt specific molecular "switches" in viral proteins that are essential for infection.

相关文章

Photorealistic lab scene depicting DoriVac DNA origami vaccine triggering strong immune responses in mouse and organ chip models, as an advance over mRNA vaccines.
AI 生成的图像

DNA origami “DoriVac” shows strong immune activation in early tests, offering a potential complement to mRNA vaccines

由 AI 报道 AI 生成的图像 事实核查

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

A repurposed breast cancer drug called MDL-001 has shown promise in lab and animal studies against a range of viruses, including flu, covid-19, RSV and norovirus. Developed by California-based Model Medicines using AI, the pill targets a conserved enzyme domain in viruses. A clinical trial is planned for early next year.

由 AI 报道

A new study reveals that giant viruses, like the mimivirus, encode parts of the cellular protein-making machinery, allowing them to direct their amoeba hosts more effectively. This capability blurs the line between living and non-living entities. Researchers suggest it enhances viral production even under stressful conditions.

Scientists at McMaster University and the Hospital for Sick Children in Canada have discovered that oligodendrocytes, cells typically supporting nerve function, aid the growth of glioblastoma by sending signals to tumor cells. Blocking this communication slowed tumor progression in lab models. The findings suggest an existing HIV drug, Maraviroc, could be repurposed for treatment.

由 AI 报道

Researchers have discovered a protein called Aurora-related kinase 1 (ARK1) that is vital for the malaria parasite's cell division. Disabling ARK1 in experiments halted the parasite's ability to replicate in both human and mosquito hosts. The finding, published in Nature Communications, highlights a potential target for new antimalarial drugs.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝